Culver City, United States
1200 Pharma, founded in 2017, is a U.S.-based startup revolutionizing the biotechnology, health care, and pharmaceutical sectors. Formed by distinguished researchers from Caltech and UCLA, the company is at the forefront of drug discovery.
With its slogan, "We leverage our breakthrough chemistry, cutting edge computation & data-rich models to accelerate drug discovery," 1200 Pharma underscores its commitment to integrating medicinal chemistry, computational design, and data-driven biological methods. This innovative approach positions them to possibly outpace traditional drug development and align medications precisely with patient needs.
In the latest financial update, 1200 Pharma secured a $2.33M venture round investment on April 15, 2024. As a company at the intersection of advanced chemistry and computation, it remains an attractive prospect for investors keen on the cutting edge of medical science.
Taros Discovery
